{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:26:24Z","timestamp":1792175184585,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24251-w","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:20:25Z","timestamp":1762424425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synthesis, in vitro, and in silico studies of 4-chlorophenyl-sulfonyl Indole based thiosemicarbazones as competitive \u03b1-glucosidase inhibitors"],"prefix":"10.1038","volume":"15","author":[{"given":"Iqra","family":"Naseer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"al-Rashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajmal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"Tawfeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shahidul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"24251_CR1","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi, P. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res. Clin. Pract. 157, 107843 (2019).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"24251_CR2","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3390\/cimb45030126","volume":"45","author":"M Szczechla","year":"2023","unstructured":"Szczechla, M., Balewska, A., Naskr\u0119t, D., Zozuli\u0144ska-Zi\u00f3\u0142kiewicz, D. & Uruska, A. Molecular changes in cells of patients with type 2 diabetes mellitus depending on changes in glycemia level in the context of Lifestyle\u2014An overview of the latest scientific discoveries. Curr. Issues. Mol. Biol. 45 (3), 1961\u20131981 (2023).","journal-title":"Curr. Issues. Mol. Biol."},{"issue":"Supplement_1","key":"24251_CR3","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"ADAPP Committee","year":"2022","unstructured":"Committee, A. D. A. P. P. & Committee:, A. D. A. P. P. 2. Classification and diagnosis of diabetes: standards of medical care in Diabetes\u20142022. Diabetes Care. 45 (Supplement_1), S17\u2013S38 (2022).","journal-title":"Diabetes Care"},{"issue":"18","key":"24251_CR4","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi, M. et al. Excess mortality among persons with type 2 diabetes. N. Engl. J. Med. 373 (18), 1720\u20131732 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"24251_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2021.11165","volume":"326","author":"JM Lawrence","year":"2021","unstructured":"Lawrence, J. M. et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001\u20132017. Jama 326 (8), 717\u2013727 (2021).","journal-title":"Jama"},{"issue":"9922","key":"24251_CR6","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn, S. E., Cooper, M. E. & Del Prato, S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383 (9922), 1068\u20131083 (2014).","journal-title":"Lancet"},{"issue":"11","key":"24251_CR7","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.2337\/dc16-0614","volume":"39","author":"JM Baena-D\u00edez","year":"2016","unstructured":"Baena-D\u00edez, J. M. et al. Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Diabetes Care. 39 (11), 1987\u20131995 (2016).","journal-title":"Diabetes Care"},{"key":"24251_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-10-679","volume":"10","author":"F Al-Maskari","year":"2010","unstructured":"Al-Maskari, F., El-Sadig, M. & Nagelkerke, N. Assessment of the direct medical costs of diabetes mellitus and its complications in the united Arab Emirates. BMC public. Health. 10, 1\u201310 (2010).","journal-title":"BMC public. Health"},{"key":"24251_CR9","doi-asserted-by":"publisher","first-page":"1192629","DOI":"10.3389\/fendo.2023.1192629","volume":"14","author":"J Ye","year":"2023","unstructured":"Ye, J. et al. The global, regional and National burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the global burden of disease study 2019. Front. Endocrinol. 14, 1192629 (2023).","journal-title":"Front. Endocrinol."},{"issue":"24","key":"24251_CR10","doi-asserted-by":"publisher","first-page":"17147","DOI":"10.3390\/ijms242417147","volume":"24","author":"R Weinberg Sibony","year":"2023","unstructured":"Weinberg Sibony, R., Segev, O., Dor, S. & Raz, I. Drug therapies for diabetes. Int. J. Mol. Sci. 24 (24), 17147 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"24251_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2010.09.010","volume":"60","author":"EA Nyenwe","year":"2011","unstructured":"Nyenwe, E. A., Jerkins, T. W., Umpierrez, G. E. & Kitabchi, A. E. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism 60 (1), 1\u201323 (2011).","journal-title":"Metabolism"},{"issue":"4","key":"24251_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s11101-021-09773-1","volume":"21","author":"AM Dirir","year":"2022","unstructured":"Dirir, A. M., Daou, M., Yousef, A. F. & Yousef, L. F. A review of alpha-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem. Rev. 21 (4), 1049\u20131079 (2022).","journal-title":"Phytochem. Rev."},{"issue":"1","key":"24251_CR13","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1038\/s41598-025-87258-3","volume":"15","author":"M Roshan","year":"2025","unstructured":"Roshan, M., Mirzazadeh, R., Tajmir-Riahi, A. & Asgari, M. S. Rational design, synthesis, in vitro, and in-silico studies of pyrazole\u2013phthalazine hybrids as new \u03b1\u2013glucosidase inhibitors. Sci. Rep. 15 (1), 3744 (2025).","journal-title":"Sci. Rep."},{"issue":"13","key":"24251_CR14","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1016\/j.bmcl.2017.05.007","volume":"27","author":"G Wang","year":"2017","unstructured":"Wang, G. et al. Synthesis, biological evaluation and molecular Docking studies of Chromone hydrazone derivatives as \u03b1-glucosidase inhibitors. Bioorg. Med. Chem. Lett. 27 (13), 2957\u20132961 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"24251_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1080\/07391102.2018.1439403","volume":"37","author":"A Mollica","year":"2019","unstructured":"Mollica, A. et al. Combinatorial peptide library screening for discovery of diverse \u03b1-glucosidase inhibitors using molecular dynamics simulations and binary QSAR models. J. Biomol. Struct. Dynamics. 37 (3), 726\u2013740 (2019).","journal-title":"J. Biomol. Struct. Dynamics"},{"key":"24251_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ejmech.2015.02.024","volume":"93","author":"JF Hsieh","year":"2015","unstructured":"Hsieh, J. F. et al. Antioxidant activity and Inhibition of \u03b1-glucosidase by hydroxyl-functionalized 2-arylbenzo [b] furans. Eur. J. Med. Chem. 93, 443\u2013451 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"24251_CR17","doi-asserted-by":"publisher","first-page":"116332","DOI":"10.1016\/j.ejmech.2024.116332","volume":"269","author":"MK Ghomi","year":"2024","unstructured":"Ghomi, M. K. et al. Evaluation of novel 2-(quinoline-2-ylthio) acetamide derivatives linked to diphenyl-imidazole as \u03b1-glucosidase inhibitors: insights from in silico, in vitro, and in vivo studies on their anti-diabetic properties. Eur. J. Med. Chem. 269, 116332 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"24251_CR18","doi-asserted-by":"publisher","first-page":"115119","DOI":"10.1016\/j.ejmech.2023.115119","volume":"249","author":"A Mushtaq","year":"2023","unstructured":"Mushtaq, A., Azam, U., Mehreen, S. & Naseer, M. M. Synthetic \u03b1-glucosidase inhibitors as promising anti-diabetic agents: recent developments and future challenges. Eur. J. Med. Chem. 249, 115119 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"24251_CR19","doi-asserted-by":"crossref","unstructured":"Abuelizz, H. A. et al. Triazoloquinazolines as a new class of potent \u03b1-glucosidase inhibitors: in vitro evaluation and docking study. PLoS ONE 14 (8), e0220379. (2019).","DOI":"10.1371\/journal.pone.0220379"},{"key":"24251_CR20","doi-asserted-by":"publisher","first-page":"134575","DOI":"10.1016\/j.molstruc.2022.134575","volume":"1274","author":"M Fan","year":"2023","unstructured":"Fan, M., Zhong, X., Huang, Y., Peng, Z. & Wang, G. Synthesis, biological evaluation and molecular Docking studies of Chromone derivatives as potential \u03b1-glucosidase inhibitors. J. Mol. Struct. 1274, 134575 (2023).","journal-title":"J. Mol. Struct."},{"issue":"21","key":"24251_CR21","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.3390\/molecules29215062","volume":"29","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Synthesis and evaluation of Phenyltriazole-Deoxynojirimycin hybrids as potent \u03b1-Glucosidase inhibitors. Molecules 29 (21), 5062 (2024).","journal-title":"Molecules"},{"issue":"1","key":"24251_CR22","first-page":"9","volume":"18","author":"TP Singh","year":"2018","unstructured":"Singh, T. P. & Singh, O. M. Recent progress in biological activities of Indole and Indole alkaloids. Mini Rev. Med. Chem. 18 (1), 9\u201325 (2018).","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"24251_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1021\/mz5001527","volume":"3","author":"KE Locock","year":"2014","unstructured":"Locock, K. E. et al. Antimicrobial polymethacrylates synthesized as mimics of tryptophan-rich cationic peptides. ACS Macro Lett. 3 (4), 319\u2013323 (2014).","journal-title":"ACS Macro Lett."},{"key":"24251_CR24","doi-asserted-by":"crossref","unstructured":"Singh, R. V., Rana, L. & Bendi, R. A. Chemistry of quinoline based heterocycle scaffolds: a comprehensive review. ChemistrySelect 7 (46), e202203648. (2022).","DOI":"10.1002\/slct.202203648"},{"key":"24251_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bioorg.2018.05.004","volume":"79","author":"MS Islam","year":"2018","unstructured":"Islam, M. S. et al. Catalytic asymmetric synthesis of Indole derivatives as novel \u03b1-glucosidase inhibitors in vitro. Bioorg. Chem. 79, 350\u2013354 (2018).","journal-title":"Bioorg. Chem."},{"issue":"13","key":"24251_CR26","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1016\/j.bmc.2014.04.033","volume":"22","author":"M Khan","year":"2014","unstructured":"Khan, M. et al. Discovery of novel oxindole derivatives as potent \u03b1-glucosidase inhibitors. Bioorg. Med. Chem. 22 (13), 3441\u20133448 (2014).","journal-title":"Bioorg. Med. Chem."},{"key":"24251_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijbiomac.2020.03.090","volume":"154","author":"AN Kawde","year":"2020","unstructured":"Kawde, A. N. et al. Exploring efficacy of indole-based dual inhibitors for \u03b1-glucosidase and \u03b1-amylase enzymes: in silico, biochemical and kinetic studies. Int. J. Biol. Macromol. 154, 217\u2013232 (2020).","journal-title":"Int. J. Biol. Macromol."},{"issue":"21","key":"24251_CR28","doi-asserted-by":"publisher","first-page":"115605","DOI":"10.1016\/j.bmc.2020.115605","volume":"28","author":"M Solangi","year":"2020","unstructured":"Solangi, M. et al. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, \u03b1-glucosidase inhibitory activity and molecular Docking studies. Bioorg. Med. Chem. 28 (21), 115605 (2020).","journal-title":"Bioorg. Med. Chem."},{"key":"24251_CR29","doi-asserted-by":"publisher","first-page":"106750","DOI":"10.1016\/j.bioorg.2023.106750","volume":"139","author":"P Sharma","year":"2023","unstructured":"Sharma, P., Gupta, G. & Asati, V. Design, synthesis and antidiabetic study of Triazole clubbed Indole derivatives as \u03b1-glucosidase inhibitors. Bioorg. Chem. 139, 106750 (2023).","journal-title":"Bioorg. Chem."},{"key":"24251_CR30","doi-asserted-by":"crossref","unstructured":"Altunoluk, O. C., \u00d6zbek, O., Kalay, E., Tokal\u0131, F. S. & Aslan, O. N. Surface characterization of barium (II)-selective potentiometric sensor based on a newly synthesized thiosemicarbazone derivative molecule. Electroanalysis 36 (7), e202300407. (2024).","DOI":"10.1002\/elan.202300407"},{"issue":"39","key":"24251_CR31","doi-asserted-by":"publisher","first-page":"28524","DOI":"10.1039\/D4RA05015K","volume":"14","author":"Z Batool","year":"2024","unstructured":"Batool, Z. et al. Design, synthesis, and in vitro and in Silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors. RSC Adv. 14 (39), 28524\u201328542 (2024).","journal-title":"RSC Adv."},{"key":"24251_CR32","doi-asserted-by":"crossref","unstructured":"Batool, Z. et al. N-hexylsulfonyl indole based thiosemicarbazones as potent and selective ecto-5\u2032-nucleotidase and NTPDase inhibitors. Bioorg.  Chem. 108717. (2025).","DOI":"10.1016\/j.bioorg.2025.108717"},{"key":"24251_CR33","doi-asserted-by":"crossref","unstructured":"Manaf, A. et al. Characterization and antioxidant activities of semicarbazide and thiosemicarbazide derivatives. J.  Chem. Soc. Pakistan 43 (4). (2021).","DOI":"10.52568\/000592"},{"key":"24251_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s43440-021-00221-7","volume":"73","author":"\u00cdT Jacob","year":"2021","unstructured":"Jacob, \u00cd. T. et al. Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors. Pharmacol. Rep. 73, 907\u2013925 (2021).","journal-title":"Pharmacol. Rep."},{"issue":"8","key":"24251_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2174\/1389557519666191029130310","volume":"20","author":"B Shakya","year":"2020","unstructured":"Shakya, B. & Yadav, P. N. Thiosemicarbazones as potent anticancer agents and their modes of action. Mini Rev. Med. Chem. 20 (8), 638\u2013661 (2020).","journal-title":"Mini Rev. Med. Chem."},{"key":"24251_CR36","doi-asserted-by":"crossref","unstructured":"Kaplanc\u0131kl\u0131, Z. A., Alt\u0131ntop, M. D., Sever, B., Cant\u00fcrk, Z. & \u00d6zdemir, A. Synthesis and in vitro evaluation of new thiosemicarbazone derivatives as potential antimicrobial agents. J. Chem. 2016 (1), 1692540. (2016).","DOI":"10.1155\/2016\/1692540"},{"issue":"1","key":"24251_CR37","doi-asserted-by":"publisher","first-page":"25754","DOI":"10.1038\/s41598-024-75100-1","volume":"14","author":"Z Batool","year":"2024","unstructured":"Batool, Z. et al. Design, synthesis, QSAR modelling and molecular dynamic simulations of N-tosyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors. Sci. Rep. 14 (1), 25754 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"24251_CR38","doi-asserted-by":"publisher","first-page":"16095","DOI":"10.1038\/s41598-022-19975-y","volume":"12","author":"A Rasool","year":"2022","unstructured":"Rasool, A. et al. Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors. Sci. Rep. 12 (1), 16095 (2022).","journal-title":"Sci. Rep."},{"key":"24251_CR39","doi-asserted-by":"publisher","first-page":"0043","DOI":"10.34133\/cbsystems.0043","volume":"4","author":"SJ Kim","year":"2023","unstructured":"Kim, S. J. et al. Bioprinting methods for fabricating in vitro tubular blood vessel models. Cyborg Bionic Syst. 4, 0043 (2023).","journal-title":"Cyborg Bionic Syst."},{"key":"24251_CR40","doi-asserted-by":"publisher","first-page":"139089","DOI":"10.1016\/j.molstruc.2024.139089","volume":"1317","author":"AR Pasha","year":"2024","unstructured":"Pasha, A. R. et al. Synthesis, in vitro \u03b1-glucosidase inhibitory potential and in Silico study of 2\u2013chloro pyridine incorporated thiosemicarbazones. J. Mol. Struct. 1317, 139089 (2024).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"24251_CR41","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41598-024-83386-4","volume":"15","author":"M Islam","year":"2025","unstructured":"Islam, M. et al. Design, synthesis, in vitro, and in Silico studies of 4-fluorocinnamaldehyde based thiosemicarbazones as urease inhibitors. Sci. Rep. 15 (1), 609 (2025).","journal-title":"Sci. Rep."},{"key":"24251_CR42","doi-asserted-by":"publisher","first-page":"129666","DOI":"10.1016\/j.molstruc.2020.129666","volume":"1231","author":"FS Tokal\u0131","year":"2021","unstructured":"Tokal\u0131, F. S., Taslimi, P., Usanmaz, H., Karaman, M. & \u015eendil, K. Synthesis, characterization, biological activity and molecular Docking studies of novel schiff bases derived from thiosemicarbazide: biochemical and computational approach. J. Mol. Struct. 1231, 129666 (2021).","journal-title":"J. Mol. Struct."},{"key":"24251_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11030-018-9839-y","volume":"22","author":"L Kang","year":"2018","unstructured":"Kang, L. et al. Structure\u2013activity relationship investigation of coumarin\u2013chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol. Diversity. 22, 893\u2013906 (2018).","journal-title":"Mol. Diversity"},{"issue":"10","key":"24251_CR44","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s13738-023-02861-3","volume":"20","author":"FS Tokal\u0131","year":"2023","unstructured":"Tokal\u0131, F. S. et al. Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes. J. Iran. Chem. Soc. 20 (10), 2631\u20132642 (2023).","journal-title":"J. Iran. Chem. Soc."},{"key":"24251_CR45","doi-asserted-by":"publisher","first-page":"101122","DOI":"10.1016\/j.cdc.2024.101122","volume":"50","author":"W Ullah","year":"2024","unstructured":"Ullah, W. et al. Synthesis of Indole based sulfonamide derivatives as potent inhibitors of \u03b1-glucosidase and \u03b1-amylase in management of type-II diabetes. Chem. Data Collections. 50, 101122 (2024).","journal-title":"Chem. Data Collections"},{"key":"24251_CR46","doi-asserted-by":"publisher","first-page":"115957","DOI":"10.1016\/j.ejmech.2023.115957","volume":"264","author":"C Hu","year":"2024","unstructured":"Hu, C. et al. Synthesis and biological evaluation of Indole derivatives containing thiazolidine-2, 4-dione as \u03b1-glucosidase inhibitors with antidiabetic activity. Eur. J. Med. Chem. 264, 115957 (2024).","journal-title":"Eur. J. Med. Chem."},{"issue":"47","key":"24251_CR47","doi-asserted-by":"publisher","first-page":"e202301884","DOI":"10.1002\/slct.202301884","volume":"8","author":"A Ullah","year":"2023","unstructured":"Ullah, A. et al. Synthesis of new indole\u2010Based thiazole derivatives as potential antiglycation and anti \u03b1\u2010Glucosidase agents: in vitro and in Silico studies. ChemistrySelect 8 (47), e202301884 (2023).","journal-title":"ChemistrySelect"},{"key":"24251_CR48","doi-asserted-by":"publisher","first-page":"138671","DOI":"10.1016\/j.molstruc.2024.138671","volume":"1312","author":"S Gul","year":"2024","unstructured":"Gul, S. et al. Discovering the anti-diabetic potential of thiosemicarbazone derivatives: in vitro \u03b1-glucosidase, \u03b1-amylase inhibitory activities with molecular Docking and DFT investigations. J. Mol. Struct. 1312, 138671 (2024).","journal-title":"J. Mol. Struct."},{"issue":"1","key":"24251_CR49","doi-asserted-by":"publisher","first-page":"18014","DOI":"10.1038\/s41598-023-44837-6","volume":"13","author":"SB Zahra","year":"2023","unstructured":"Zahra, S. B. et al. Synthesis of novel coumarin-based thiosemicarbazones and their implications in diabetic management via in-vitro and in-silico approaches. Sci. Rep. 13 (1), 18014 (2023).","journal-title":"Sci. Rep."},{"issue":"4","key":"24251_CR50","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/molecules30040788","volume":"30","author":"X Ni","year":"2025","unstructured":"Ni, X., Luo, X., Jiang, X., Chen, W. & Bai, R. Small-Molecule tyrosinase inhibitors for treatment of hyperpigmentation. Molecules 30 (4), 788 (2025).","journal-title":"Molecules"},{"key":"24251_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bioorg.2017.01.017","volume":"71","author":"F Chaudhry","year":"2017","unstructured":"Chaudhry, F. et al. A. In search of new \u03b1-glucosidase inhibitors: Imidazolylpyrazole derivatives. Bioorg. Chem. 71, 102\u2013109 (2017).","journal-title":"Bioorg. Chem."},{"key":"24251_CR52","unstructured":"Release, S. 4: Desmond Molecular Dynamics System. (DE Shaw Research, 2017)."},{"key":"24251_CR53","doi-asserted-by":"publisher","first-page":"1597454","DOI":"10.3389\/fchem.2025.1597454","volume":"13","author":"M Bashir","year":"2025","unstructured":"Bashir, M., Abdullah, U., Siddique, F. & Jalal, N. Computational advances in the design and discovery of Artemis inhibitors for radiosensitization in cancer therapy. Front. Chem. 13, 1597454 (2025).","journal-title":"Front. Chem."},{"key":"24251_CR54","doi-asserted-by":"crossref","unstructured":"Abida Ejaz, S. et al. Computational exploration of fluorocyclopentenyl-purines and\u2010pyrimidines derivatives as potential inhibitors of epidermal growth factor receptor (EGFR) for the treatment of breast cancer. Chem. Biodivers. 20 (12), e202301190. (2023).","DOI":"10.1002\/cbdv.202301190"},{"issue":"2","key":"24251_CR55","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1142\/S2737416525500437","volume":"25","author":"M Bashir","year":"2026","unstructured":"Bashir, M. et al. Computational insights into Structural, optoelectronic and charge transfer properties of monocarbonyl Curcumin derivatives for biomedical and photonic applications. J. Comput. Biophys. Chem. 25 (2), 185\u2013211 (2026).","journal-title":"J. Comput. Biophys. Chem."},{"issue":"6","key":"24251_CR56","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1142\/S2737416525500747","volume":"25","author":"M Wajid","year":"2026","unstructured":"Wajid, M. et al. Synthesis, biological Assessment, and computational analysis of sulfathiazole schiff bases. J. Comput. Biophys. Chem. 25 (6), 893\u2013917 (2026).","journal-title":"J. Comput. Biophys. Chem."},{"issue":"2","key":"24251_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1021\/ct700248k","volume":"4","author":"J Tirado-Rives","year":"2008","unstructured":"Tirado-Rives, J. & Jorgensen, W. L. Performance of B3LYP density functional methods for a large set of organic molecules. J. Chem. Theory Comput. 4 (2), 297\u2013306 (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"24251_CR58","doi-asserted-by":"crossref","unstructured":"Naseer, I. et al. Antidiabetic assessment, metal chelating impacts, and computational modeling of 4-fluorophenyl sulfonyl-indole based hydrazones. J.  Mol. Struct. 143878. (2025).","DOI":"10.1016\/j.molstruc.2025.143878"},{"issue":"2","key":"24251_CR59","first-page":"155","volume":"13","author":"M Sheikhi","year":"2016","unstructured":"Sheikhi, M., Balali, E. & Lari, H. Theoretical investigations on molecular structure, NBO, HOMO-LUMO and MEP analysis of two crystal structures of N-(2-benzoyl-phenyl) oxalyl: A DFT study. J. Phys. Theoretical Chem. 13 (2), 155\u2013169 (2016).","journal-title":"J. Phys. Theoretical Chem."},{"issue":"21","key":"24251_CR60","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","volume":"22","author":"BJ Grant","year":"2006","unstructured":"Grant, B. J., Rodrigues, A. P., ElSawy, K. M., McCammon, J. A. & Caves, L. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 22 (21), 2695\u20132696 (2006).","journal-title":"Bioinformatics"},{"key":"24251_CR61","unstructured":"Team, R. C. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2016)."},{"issue":"1","key":"24251_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14 (1), 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"24251_CR63","unstructured":"Gowers, R. J. et al. MDAnalysis: a Python Package for the Rapid Analysis of Molecular Dynamics Simulations (Los Alamos National Laboratory (LANL),  2019)."},{"issue":"10","key":"24251_CR64","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/jcc.21787","volume":"32","author":"N Michaud-Agrawal","year":"2011","unstructured":"Michaud-Agrawal, N., Denning, E. J., Woolf, T. B. & Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 32 (10), 2319\u20132327 (2011).","journal-title":"J. Comput. Chem."},{"key":"24251_CR65","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.compbiolchem.2020.107322","volume":"87","author":"LP Kagami","year":"2020","unstructured":"Kagami, L. P., das Neves, G. M., Timmers, L. F. S. M., Caceres, R. A. & Eifler-Lima, V. L. Geo-Measures: A PyMOL plugin for protein structure ensembles analysis. Comput. Biol. Chem. 87, 107322 (2020).","journal-title":"Comput. Biol. Chem."},{"key":"24251_CR66","first-page":"8","volume":"1","author":"L Schrodinger","year":"2015","unstructured":"Schrodinger, L. The PyMOL molecular graphics system. Version 1, 8 (2015).","journal-title":"Version"},{"issue":"1","key":"24251_CR67","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1080\/14756366.2019.1660653","volume":"34","author":"J Jenis","year":"2019","unstructured":"Jenis, J. et al. Competitive \u03b1-glucosidase inhibitors, dihydrobenzoxanthones, from the barks of Artocarpus elasticus. J. Enzyme Inhib. Med. Chem. 34 (1), 1623\u20131632 (2019).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"24251_CR68","doi-asserted-by":"publisher","first-page":"106739","DOI":"10.1016\/j.bioorg.2023.106739","volume":"139","author":"R Basri","year":"2023","unstructured":"Basri, R. et al. Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as \u03b1-glucosidase inhibitors. Bioorg. Chem. 139, 106739 (2023).","journal-title":"Bioorg. Chem."},{"key":"24251_CR69","doi-asserted-by":"publisher","first-page":"108155","DOI":"10.1016\/j.bioorg.2025.108155","volume":"156","author":"R Farooqi","year":"2025","unstructured":"Farooqi, R. et al. Design, synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as \u03b1-glucosidase inhibitors. Bioorg. Chem. 156, 108155 (2025).","journal-title":"Bioorg. Chem."},{"issue":"8","key":"24251_CR70","doi-asserted-by":"publisher","first-page":"2400140","DOI":"10.1002\/ardp.202400140","volume":"357","author":"RD Alharthy","year":"2024","unstructured":"Alharthy, R. D. et al. Synthesis of the chromone-thiosemicarbazone scaffold as promising \u03b1\u2010glucosidase inhibitors: an in vitro and in Silico approach toward antidiabetic drug design. Arch. Pharm. 357 (8), 2400140 (2024).","journal-title":"Arch. Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24251-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24251-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:03:50Z","timestamp":1762427030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24251-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24251"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24251-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38832"}}